CHI Insight Pharma Reports

CHA Advances Reports are a service of Cambridge Healthtech Advisors. Advances Reports are written by experts who collaborate with CHA to provide a series of reports that evaluate the salient trends in pharmaceutical technology, business, and therapy markets.

Advances Reports offer:

Current information and analysis of R&D technologies, therapeutic markets, and critical business issues.
Analysis of the probability of success for various applications of each technology.
Interviews with key personnel in companies at the forefront of technological advances.
Competitive insight on the business strategies and activities of key companies.

...Show More ...Show Less

3 Reports from CHI Insight Pharma Reports

Sort by:

Building Digital Assistants, Virtual Agents, and Chatbots: A Vendor Guide

Aug 01, 2018 | USD 1,995

... by text or voice conversations—has passed well beyond the tipping point of usability and is supporting true interactive conversations. The number of channels that support this intuitive connection with digital systems has exploded—mobile apps, customer ... Read More
Commercializing Novel IVDs: A Comprehensive Manual for Success 2019 Supplement

Jul 01, 2018 | USD 199

... This brief supplement to Commercializing Novel IVDs: A Comprehensive Manual for Success presents an abbreviated overview of the most important changes impacting the IVD industry. Regulatory changes in the United States (US) and European Union ... Read More
Patient Enrollment and Recruitment Market Study 2018

Apr 01, 2018 | USD 399

... Patient Engagement Technologies that Run Trials Each year Insight Pharma Reports, a sister publishing arm to Clinical Informatics News conducts a survey of 100, qualified respondents seeking insight into the trends in clinical trial patient ... Read More